These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [New pharmacological approaches: rhDNase]. Tournier G, Sardet A, Grosskopf C, Baculard A, Delaisi B. Rev Pneumol Clin; 1995 Apr 15; 51(3):193-200. PubMed ID: 7569583 [Abstract] [Full Text] [Related]
13. The clinical use of rhDNAse. Davies J, Trindale M, Wallis C, Rosenthal M, Bush A. Pediatr Pulmonol Suppl; 1997 Apr 15; 16():273-4. PubMed ID: 9443309 [No Abstract] [Full Text] [Related]
15. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group. Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark AR. Chest; 1995 Jul 15; 108(1):153-6. PubMed ID: 7606951 [Abstract] [Full Text] [Related]
17. Early treatment with dornase alfa in cystic fibrosis: what are the issues? Bush A. Pediatr Pulmonol; 1998 Feb 15; 25(2):79-82. PubMed ID: 9516089 [No Abstract] [Full Text] [Related]
19. The use of recombinant human dornase alfa in CF. Cox C. Paediatr Nurs; 1995 Nov 15; 7(9):29-31. PubMed ID: 8705343 [No Abstract] [Full Text] [Related]